An 18-month-old in London, England, is one of the youngest children to receive gene therapy to treat hearing loss caused by a mutation in the OTOF gene. This gene produces a protein called Otoferlin that allows for communication between cells of the cochlea and the brain.

The recipient received an infusion of a functional copy of the OTOF in her ear. The procedure was completed in just 16 minutes. Reportedly, it only took a few weeks for the child to begin to hear and respond to sounds without the help of her cochlear implant.

Read the full article

References

Afzali K. (2024) Toddler born deaf can hear after gene therapy trial breakthrough her parents call “mind-blowing.”CBS News(accessed May 13, 2024).

Share this

Related Posts

Admission Rates of Neonatal Intensive Care Units in the United States

A New Flexible Auditory Brainstem Implant

Prevalence of Depression in Teenagers and Adults in the United States

Recent Posts

Capitol hill building in the morning with colorful cloud , Washington DC.

Academy, ADA, and ASHA Announce the Introduction of MAAIA in the Senate

The American Academy of Audiology, Academy of Doctors of Audiology (ADA), and American Speech-Language-Hearing Association (ASHA) are pleased to announce the introduction of the Medicare…

Read More

Admission Rates of Neonatal Intensive Care Units in the United States

Pediatric audiology case-history questionnaires often ask about birth history and time spent in a neonatal intensive care unit (NICU). As such, audiologists who routinely see…

Read More

A New Flexible Auditory Brainstem Implant

An auditory brainstem implant (ABI) provides the sensation of sound to individuals who are deaf due to neurofibromatosis 2 (NF2) or a severely compromised or…

Read More